A Systematic Review of Antibiotic Resistance Trends and Treatment Options for Hospital-Acquired Multidrug-Resistant Infections

Overview

Journal Cureus

Specialty Biomedical Engineering

Date 2022 Nov 16

PMID 36381838

Authors

Walter Y Agyeman

Aakash Bisht

Ankit Gopinath

Ameer Haider Cheema

Keyur Chaludiya

Maham Khalid

Marcellina Nwosu

Srujana Konka

Safeera Khan

Affiliations

Soon will be listed here.

Abstract

Antimicrobial resistance is a major public health challenge described by the World Health Organization as one of the top 10 public health challenges worldwide. Drug-resistant microbes contribute significantly to morbidity and mortality in the hospital, especially in the critical care unit. The primary etiology of increasing antibiotic resistance is inappropriate and excessive use of antibiotics. The alarming rise of drug-resistant microbes worldwide threatens to erode our ability to treat infections with our current armamentarium of antibiotics. Unfortunately, the pace of development of new antibiotics by the pharmaceutical industry has not kept up with rising resistance to expand our options to treat microbial infections. The costs of antibiotic resistance include death and disability, extended hospital stays due to prolonged sickness, need for expensive therapies, rising healthcare expenditure, reduced productivity from time out of the workforce, and rising penury. This review sums up the common mechanisms, trends, and treatment options for hospital-acquired multidrug-resistant microbes.

Citing Articles

From Cure to Crisis: Understanding the Evolution of Antibiotic-Resistant Bacteria in Human Microbiota.

Tahmasebi H, Arjmand N, Monemi M, Babaeizad A, Alibabaei F, Alibabaei N Biomolecules. 2025; 15(1).

PMID: 39858487 PMC: 11764262. DOI: 10.3390/biom15010093.

The Most Common Multi-Drug Resistant Bacteria Associated with Hospital Infections, in Urmia, Iran.

Mousavi S, Nezhadrahim R, Abdulzadeh F Iran J Pathol. 2024; 19(3):283-291.

PMID: 39687456 PMC: 11646194. DOI: 10.30699/IJP.2024.2014294.3195.

Presepsin Does Not Predict Risk of Death in Sepsis Patients Admitted to the Intensive Care Unit: A Prospective Single-Center Study.

Pluta M, Czempik P, Kwiatkowska M, Marczyk-Belbot K, Maslanka S, Mika J Biomedicines. 2024; 12(10).

PMID: 39457628 PMC: 11504983. DOI: 10.3390/biomedicines12102313.

Resistome in a changing environment: Hotspots and vectors of spreading with a focus on the Russian-Ukrainian War.

Symochko L, Pereira P, Demyanyuk O, Pinheiro M, Barcelo D Heliyon. 2024; 10(12):e32716.

PMID: 39183836 PMC: 11341293. DOI: 10.1016/j.heliyon.2024.e32716.

The challenge of antimicrobial resistance (AMR): current status and future prospects.

Ferrara F, Castagna T, Pantolini B, Campanardi M, Roperti M, Grotto A Naunyn Schmiedebergs Arch Pharmacol. 2024; 397(12):9603-9615.

PMID: 39052061 DOI: 10.1007/s00210-024-03318-x.

References

Tandogdu Z, Wagenlehner F . Global epidemiology of urinary tract infections. Curr Opin Infect Dis. 2015; 29(1):73-9. DOI: 10.1097/QCO.0000000000000228. View

Silva-Santana G, Silva C, Olivella J, Silva I, Fernandes L, Sued-Karam B . Worldwide survey of Corynebacterium striatum increasingly associated with human invasive infections, nosocomial outbreak, and antimicrobial multidrug-resistance, 1976-2020. Arch Microbiol. 2021; 203(5):1863-1880. PMC: 7903872. DOI: 10.1007/s00203-021-02246-1. View

Seo J, Song R . [Effect of 2% Chlorhexidine Bathing on the Incidence of Hospital-Acquired Infection and Multidrug-Resistant Organisms in Adult Intensive Care Unit Patients: Systematic Review and Meta-Analysis]. J Korean Acad Nurs. 2021; 51(4):414-429. DOI: 10.4040/jkan.21046. View

Geisinger E, Isberg R . Interplay Between Antibiotic Resistance and Virulence During Disease Promoted by Multidrug-Resistant Bacteria. J Infect Dis. 2017; 215(suppl_1):S9-S17. PMC: 5853982. DOI: 10.1093/infdis/jiw402. View

Khorvash F, Yaghoubi S, Farsaei S, Ataei B, Hakamifard A, Mohajeri F . Comparison of two therapeutic approaches for the management of ventilator-associated pneumonia due to multidrug-resistant Acinetobacter: a randomized clinical trial study. J Immunoassay Immunochem. 2019; 41(1):97-105. DOI: 10.1080/15321819.2019.1696818. View

Dey N, Kamatchi C, Vickram A, Anbarasu K, Thanigaivel S, Palanivelu J . Role of nanomaterials in deactivating multiple drug resistance efflux pumps - A review. Environ Res. 2021; 204(Pt A):111968. DOI: 10.1016/j.envres.2021.111968. View

Davey P, Marwick C, Scott C, Charani E, McNeil K, Brown E . Interventions to improve antibiotic prescribing practices for hospital inpatients. Cochrane Database Syst Rev. 2017; 2:CD003543. PMC: 6464541. DOI: 10.1002/14651858.CD003543.pub4. View

DAccolti M, Soffritti I, Mazzacane S, Caselli E . Fighting AMR in the Healthcare Environment: Microbiome-Based Sanitation Approaches and Monitoring Tools. Int J Mol Sci. 2019; 20(7). PMC: 6479322. DOI: 10.3390/ijms20071535. View

Bougnoux M, Brun S, Zahar J . Healthcare-associated fungal outbreaks: New and uncommon species, New molecular tools for investigation and prevention. Antimicrob Resist Infect Control. 2018; 7:45. PMC: 5870726. DOI: 10.1186/s13756-018-0338-9. View

10.

Septimus E . Antimicrobial Resistance: An Antimicrobial/Diagnostic Stewardship and Infection Prevention Approach. Med Clin North Am. 2018; 102(5):819-829. DOI: 10.1016/j.mcna.2018.04.005. View

11.

Mehl A, Asvold B, Kummel A, Lydersen S, Paulsen J, Haugan I . Trends in antimicrobial resistance and empiric antibiotic therapy of bloodstream infections at a general hospital in Mid-Norway: a prospective observational study. BMC Infect Dis. 2017; 17(1):116. PMC: 5288893. DOI: 10.1186/s12879-017-2210-6. View

12.

Martin-Loeches I, Rodriguez A, Torres A . New guidelines for hospital-acquired pneumonia/ventilator-associated pneumonia: USA vs. Europe. Curr Opin Crit Care. 2018; 24(5):347-352. DOI: 10.1097/MCC.0000000000000535. View

13.

MacVane S . Antimicrobial Resistance in the Intensive Care Unit: A Focus on Gram-Negative Bacterial Infections. J Intensive Care Med. 2016; 32(1):25-37. DOI: 10.1177/0885066615619895. View

14.

Mea H, Yong P, Wong E . An overview of Acinetobacter baumannii pathogenesis: Motility, adherence and biofilm formation. Microbiol Res. 2021; 247:126722. DOI: 10.1016/j.micres.2021.126722. View

15.

Asri N, Ahmad S, Mohamud R, Mohd Hanafi N, Mohd Zaidi N, Irekeola A . Global Prevalence of Nosocomial Multidrug-Resistant : A Systematic Review and Meta-Analysis. Antibiotics (Basel). 2021; 10(12). PMC: 8698758. DOI: 10.3390/antibiotics10121508. View

16.

Fernando S, Gray T, Gottlieb T . Healthcare-acquired infections: prevention strategies. Intern Med J. 2017; 47(12):1341-1351. DOI: 10.1111/imj.13642. View

17.

Juan C, Pena C, Oliver A . Host and Pathogen Biomarkers for Severe Pseudomonas aeruginosa Infections. J Infect Dis. 2017; 215(suppl_1):S44-S51. DOI: 10.1093/infdis/jiw299. View

18.

Spivak E, Hanson K . Candida auris: an Emerging Fungal Pathogen. J Clin Microbiol. 2017; 56(2). PMC: 5786713. DOI: 10.1128/JCM.01588-17. View

19.

Septimus E, Schweizer M . Decolonization in Prevention of Health Care-Associated Infections. Clin Microbiol Rev. 2016; 29(2):201-22. PMC: 4786886. DOI: 10.1128/CMR.00049-15. View

20.

Maxwell R, Croft C, Creech C, Thomsen I, Soper N, Brown L . Methicillin-Resistant Staphylococcus aureus in a Trauma Population: Does Decolonization Prevent Infection?. Am Surg. 2018; 83(12):1407-1412. View